Lytham Partners Designs Moleculin Biotech’s 2018 Annual Report
Lytham Partners Designs Moleculin Biotech’s (Nasdaq: MBRX) 2018 Annual Report View MBRX Annual Report
Soliton, Inc.
Nasdaq: SOLY Sector: Healthcare Industry: Medical Devices Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from MD Anderson. The Company’s first planned commercial product is designed to use rapid pulses of designed acoustic shockwaves in conjunction with existing lasers to accelerate the removal of unwanted tattoos (RAP device).…
Lytham Partners Unveils New Website for Moleculin Biotech (Nasdaq: MBRX)
Lytham Partners Unveils New Website for Moleculin Biotech, Inc. (Nasdaq: MBRX) VIEW THE NEW MBRX WEBSITE
Introducing our newest client, WOW Unlimited Media (TSXV: WOW; OTCQX: WOWMF)!
Introducing our newest client, WOW Unlimited Media (TSXV: WOW; OTCQX: WOWMF)! LEARN MORE
Lytham Partners Designs S&W Seed Company 2018 Annual Report
Lytham Partners Designs S&W Seed Company (Nasdaq: SANW) 2018 Annual Report View SANW Annual Report
Co-Diagnostics to Present at the Lytham Partners Virtual Investor Conference
Co-Diagnostics CEO to Discuss Progress and Forecasts in a Lytham Partners’ Virtual Investors Conference Presentation on Tuesday, December 4, 2018 at 4:00 pm ET Event: Lytham Partners Virtual Investor Conference Date: December 4, 2018 Time: 4:00PM ET Webcast: https://lythampartners.com/vic.aspx or by accessing the link here LEARN MORE
Tag Oil to Present at the Lytham Partners Virtual Investor Conference
Tag Oil to Present at the Lytham Partners Virtual Investor Conference on November 15, 2018 At 2:00pm ET Event: Lytham Partners Virtual Investor Conference Date: November 15, 2018 Time: 2:00pm ET / 11:00am PT Webcast: https://lythampartners.com/vic.aspx or by accessing the link here LEARN MORE
BioNovo, Inc.
Nasdaq: BNVO* Sector: Healthcare Industry: Pharmaceuticals Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of drugs for the treatment of unmet medical needs in women’s health and cancer in the United States. The company’s drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds. Its…
Bioheart, Inc.
Nasdaq: BHRT* Sector: Healthcare Industry: Biotechnology Bioheart, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell based therapeutics that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.…
Aradigm Corporation
Nasdaq: ARDM* Sector: Healthcare Industry: Specialty Pharmaceuticals Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs for the prevention and treatment of severe respiratory diseases. Aradigm has completed two Phase 3 trials with Linhaliq, an investigational proprietary formulation of ciprofloxacin for inhalation for the treatment of non-cystic fibrosis BE and submitted an NDA…